Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2013

01.09.2013 | Urologic Oncology

Tumor Volume Adds Prognostic Value in Patients with Organ-Confined Prostate Cancer

verfasst von: Kwang Hyun Kim, MD, Sey Kiat Lim, MBBS, MRCS, MMed, FAMS, Tae-Young Shin, MD, Dae Ryong Kang, PhD, Woong Kyu Han, MD, PhD, Byung Ha Chung, MD, PhD, Koon Ho Rha, MD, PhD, FACS, Sung Joon Hong, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study was designed to assess the independent prognostic value of tumor volume (TV) and whether adding TV provides additional prognostic information for predicting biochemical recurrence (BCR) after radical prostatectomy.

Methods

We reviewed the medical records of 1,129 patients who underwent radical prostatectomy between July 2005 and July 2011. TV was categorized as minimal (≤1.0 ml), moderate (1.1–5.0 ml), or extensive (>5.0 ml). Cox regression analysis was performed to identify independent predictors of BCR. The predictive accuracies of Cox’s proportional hazard regression models with and without TV were quantified and compared using time-dependent receiver operating characteristic curve analysis.

Results

Increasing TV was associated with higher prostate specific antigen, pathological Gleason score, and pathologic tumor stage. TV was an independent predictor of BCR in multivariate analysis (p < 0.001). When patients were stratified by organ-confined and nonorgan-confined tumor groups, TV remained an independent predictor of BCR in organ-confined tumors (p < 0.001). In the nonorgan-confined tumor group, a significant difference was found only between extensive versus minimal TV (p = 0.023). The predictive accuracy of the Cox regression model increased significantly by adding TV in organ-confined tumor group (0.748 vs. 0.704, p < 0.05) but not in nonorgan-confined group (0.742 vs. 0.734, p > 0.05).

Conclusions

TV was an independent prognostic predictor of BCR in organ-confined prostate cancers and provided additional prognostic information with increased predictive accuracy. In contrast, TV did not increase the predictive accuracy in nonorgan-confined tumor. TV should be considered as a prognosticator in organ-confined tumors.
Literatur
1.
Zurück zum Zitat Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281:1395–400.PubMedCrossRef Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281:1395–400.PubMedCrossRef
2.
Zurück zum Zitat Vollmer RT. Percentage of tumor in prostatectomy specimens: a study of American Veterans. Am J Clin Pathol. 2009;131:86–91.PubMedCrossRef Vollmer RT. Percentage of tumor in prostatectomy specimens: a study of American Veterans. Am J Clin Pathol. 2009;131:86–91.PubMedCrossRef
3.
Zurück zum Zitat Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol. 2004;172:137–40.PubMedCrossRef Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol. 2004;172:137–40.PubMedCrossRef
4.
Zurück zum Zitat Eichelberger LE, Koch MO, Eble JN, Ulbright TM, Juliar BE, Cheng L. Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Mod Pathol. 2005;18:886–90.PubMedCrossRef Eichelberger LE, Koch MO, Eble JN, Ulbright TM, Juliar BE, Cheng L. Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Mod Pathol. 2005;18:886–90.PubMedCrossRef
5.
Zurück zum Zitat Marks RA, Lin H, Koch MO, Cheng L. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence. Am J Surg Pathol. 2007;31:877–81.PubMedCrossRef Marks RA, Lin H, Koch MO, Cheng L. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence. Am J Surg Pathol. 2007;31:877–81.PubMedCrossRef
6.
Zurück zum Zitat Chun FK, Briganti A, Jeldres C, et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer. 2007;43:536–43.PubMedCrossRef Chun FK, Briganti A, Jeldres C, et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer. 2007;43:536–43.PubMedCrossRef
7.
Zurück zum Zitat Salomon L, Levrel O, Anastasiadis AG, et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol. 2003;43:39–44.PubMedCrossRef Salomon L, Levrel O, Anastasiadis AG, et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol. 2003;43:39–44.PubMedCrossRef
8.
Zurück zum Zitat Porten SP, Cooperberg MR, Carroll PR. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease. BJU Int. 2010;105:472–5.PubMedCrossRef Porten SP, Cooperberg MR, Carroll PR. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease. BJU Int. 2010;105:472–5.PubMedCrossRef
9.
Zurück zum Zitat Wolters T, Roobol MJ, van Leeuwen PJ, et al. Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol. 2010;57:821–9.PubMedCrossRef Wolters T, Roobol MJ, van Leeuwen PJ, et al. Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol. 2010;57:821–9.PubMedCrossRef
10.
Zurück zum Zitat Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol. 2004;172:508–11.PubMedCrossRef Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol. 2004;172:508–11.PubMedCrossRef
11.
Zurück zum Zitat van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen vandeKaa CA. Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer. World J Urol. 2008;26:237–41.PubMedCrossRef van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen vandeKaa CA. Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer. World J Urol. 2008;26:237–41.PubMedCrossRef
12.
Zurück zum Zitat Epstein JI. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol. 2011;186:790–7.PubMedCrossRef Epstein JI. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol. 2011;186:790–7.PubMedCrossRef
13.
Zurück zum Zitat Renshaw AA, Chang H, D’Amico AV. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol. 1997;107:704–8.PubMed Renshaw AA, Chang H, D’Amico AV. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol. 1997;107:704–8.PubMed
14.
Zurück zum Zitat Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92–105.PubMedCrossRef Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92–105.PubMedCrossRef
15.
Zurück zum Zitat Hyun SH, Choi JY, Shim YM, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2010;17:115–22.PubMedCrossRef Hyun SH, Choi JY, Shim YM, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2010;17:115–22.PubMedCrossRef
16.
Zurück zum Zitat Nelson BA, Shappell SB, Chang S, Wells N, Farnham SB, Smith JA, Cookson MS. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int. 2006;97:1169–72.PubMedCrossRef Nelson BA, Shappell SB, Chang S, Wells N, Farnham SB, Smith JA, Cookson MS. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int. 2006;97:1169–72.PubMedCrossRef
17.
Zurück zum Zitat Uhlman MA, Sun L, Stackhouse DA, et al. Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate. J Urol. 2010;183:997–1001.PubMedCrossRef Uhlman MA, Sun L, Stackhouse DA, et al. Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate. J Urol. 2010;183:997–1001.PubMedCrossRef
18.
Zurück zum Zitat Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol. 1993;149:1478–81.PubMed Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol. 1993;149:1478–81.PubMed
19.
Zurück zum Zitat Noguchi M, Stamey TA, McNeal JE, Yemoto CE. Assessment of morphometric measurements of prostate carcinoma volume. Cancer. 2000;89:1056–64.PubMedCrossRef Noguchi M, Stamey TA, McNeal JE, Yemoto CE. Assessment of morphometric measurements of prostate carcinoma volume. Cancer. 2000;89:1056–64.PubMedCrossRef
20.
Zurück zum Zitat van der Kwast TH, Amin MB, Billis A, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol. 2011;24:16–25.PubMedCrossRef van der Kwast TH, Amin MB, Billis A, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol. 2011;24:16–25.PubMedCrossRef
21.
Zurück zum Zitat Chen ME, Johnston D, Reyes AO, Soto CP, Babaian RJ, Troncoso P. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol. 2003;27:1291–301.PubMedCrossRef Chen ME, Johnston D, Reyes AO, Soto CP, Babaian RJ, Troncoso P. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol. 2003;27:1291–301.PubMedCrossRef
22.
Zurück zum Zitat Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol. 1990;21:799–804.PubMedCrossRef Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol. 1990;21:799–804.PubMedCrossRef
23.
Zurück zum Zitat Cheng WS, Frydenberg M, Bergstralh EJ, Larson Keller JJ, Zincke H. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology. 1993;42:283–91.PubMedCrossRef Cheng WS, Frydenberg M, Bergstralh EJ, Larson Keller JJ, Zincke H. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology. 1993;42:283–91.PubMedCrossRef
24.
Zurück zum Zitat Song C, Ro JY, Lee M, et al. Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology. 2006;68:820–4.PubMedCrossRef Song C, Ro JY, Lee M, et al. Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology. 2006;68:820–4.PubMedCrossRef
25.
Zurück zum Zitat Merrill M, Lane BR, Reuther AM, Zhou M, Magi Galluzzi C, Klein EA. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology. 2007;70:294–8.PubMedCrossRef Merrill M, Lane BR, Reuther AM, Zhou M, Magi Galluzzi C, Klein EA. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology. 2007;70:294–8.PubMedCrossRef
26.
Zurück zum Zitat Hashimoto K, Masumori N, Takei F, et al. Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy. Jpn J Clin Oncol. 2008;38:31–5.PubMedCrossRef Hashimoto K, Masumori N, Takei F, et al. Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy. Jpn J Clin Oncol. 2008;38:31–5.PubMedCrossRef
27.
Zurück zum Zitat Jeong CW, Jeong SJ, Hong SK, et al. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis. Int J Urol. 2012;19:846–52.PubMedCrossRef Jeong CW, Jeong SJ, Hong SK, et al. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis. Int J Urol. 2012;19:846–52.PubMedCrossRef
28.
Zurück zum Zitat Song C, Seo S, Ahn H, et al. Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis. Int J Clin Oncol. 2012;17:355–60.PubMedCrossRef Song C, Seo S, Ahn H, et al. Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis. Int J Clin Oncol. 2012;17:355–60.PubMedCrossRef
29.
Zurück zum Zitat Marchetti PE, Shikanov S, Razmaria A, Zagaja GP, Shalhav AL. Impact of prostate weight on probability of positive surgical margins in patients with low-risk prostate cancer after robotic-assisted laparoscopic radical prostatectomy. Urology. 2011;77:677–81.PubMedCrossRef Marchetti PE, Shikanov S, Razmaria A, Zagaja GP, Shalhav AL. Impact of prostate weight on probability of positive surgical margins in patients with low-risk prostate cancer after robotic-assisted laparoscopic radical prostatectomy. Urology. 2011;77:677–81.PubMedCrossRef
30.
Zurück zum Zitat Sherwin JC, Mirmilstein G, Pedersen J, Lawrentschuk N, Bolton D, Mills J. Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors. J Urol. 2010;183:1808–14.PubMedCrossRef Sherwin JC, Mirmilstein G, Pedersen J, Lawrentschuk N, Bolton D, Mills J. Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors. J Urol. 2010;183:1808–14.PubMedCrossRef
31.
Zurück zum Zitat Cheng L, Koch MO, Juliar BE, Daggy JK, Foster RS, Bihrle R, et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol. 2005;23:2911–7.PubMedCrossRef Cheng L, Koch MO, Juliar BE, Daggy JK, Foster RS, Bihrle R, et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol. 2005;23:2911–7.PubMedCrossRef
32.
Zurück zum Zitat Palisaar RJ, Graefen M, Karakiewicz PI, et al. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur Urol. 2002;41:155–61.PubMedCrossRef Palisaar RJ, Graefen M, Karakiewicz PI, et al. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur Urol. 2002;41:155–61.PubMedCrossRef
Metadaten
Titel
Tumor Volume Adds Prognostic Value in Patients with Organ-Confined Prostate Cancer
verfasst von
Kwang Hyun Kim, MD
Sey Kiat Lim, MBBS, MRCS, MMed, FAMS
Tae-Young Shin, MD
Dae Ryong Kang, PhD
Woong Kyu Han, MD, PhD
Byung Ha Chung, MD, PhD
Koon Ho Rha, MD, PhD, FACS
Sung Joon Hong, MD, PhD
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3016-4

Weitere Artikel der Ausgabe 9/2013

Annals of Surgical Oncology 9/2013 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.